Package 0008-4994-20

{"route": ["INTRAVENOUS"], "spl_id": "632c318a-2046-484c-9b5d-af354cbca86a", "openfda": {"nui": ["N0000175938", "M0021223"], "unii": ["70JE2N95KR"], "rxcui": ["581531", "584201"], "spl_set_id": ["fd826e47-1b77-4ffd-bb22-fda3379903b0"], "pharm_class_cs": ["Tetracyclines [CS]"], "pharm_class_epc": ["Tetracycline-class Antibacterial [EPC]"], "manufacturer_name": ["Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, SINGLE-DOSE in 1 CARTON (0008-4994-20)  / 5 mL in 1 VIAL, SINGLE-DOSE (0008-4994-19)", "package_ndc": "0008-4994-20", "marketing_start_date": "20170208"}], "brand_name": "Tygacil", "product_id": "0008-4994_632c318a-2046-484c-9b5d-af354cbca86a", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Tetracycline-class Antibacterial [EPC]", "Tetracyclines [CS]"], "product_ndc": "0008-4994", "generic_name": "TIGECYCLINE", "labeler_name": "Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tygacil", "active_ingredients": [{"name": "TIGECYCLINE", "strength": "50 mg/5mL"}], "application_number": "NDA021821", "marketing_category": "NDA", "marketing_start_date": "20170208", "listing_expiration_date": "20261231"}